The Association between Prolonged Jaundice and UGT1A1 Gene Polymorphism (G71R) in Gilbert's Syndrome

Ehsan Alaee1, Behnaz Bazrafshan2, Ali Reza Azaminejad3

  • 1Assistant Professor, Department of Paediatrics and Neonatology, Neonatal and Children's Health Research Center, Golestan, University of Medical Sciences , Gorgan, Iran .

Insights

This study found no direct link between prolonged jaundice and the G71R polymorphism in Gilbert's syndrome. However, a correlation was observed between prolonged jaundice in males and this specific genetic variation.

Area of Science:

  • Medical Genetics
  • Neonatology
  • Pediatrics

Background:

  • Neonatal jaundice is common, with prolonged cases affecting many breastfed infants.
  • Genetic factors are considered influential in the incidence of neonatal jaundice.
  • This study investigated the role of genetic polymorphisms in prolonged jaundice.

Purpose of the Study:

  • To determine the association between prolonged jaundice and the G71R polymorphism in Gilbert's syndrome.
  • To explore potential genetic underpinnings of prolonged neonatal jaundice.

Main Methods:

  • A case-control study was conducted with 87 jaundiced infants (over 2 weeks) and 81 healthy controls.
  • DNA was extracted using the phenol-chloroform method.
  • Polymerase Chain Reaction with Confronting Two-Pair Primers (PCR-CTPP) was used to analyze the UGT1A1 G71R polymorphism.

Main Results:

  • No significant difference in Gilbert genotype distribution was found between study and control groups (p=0.772).
  • A correlation was observed between prolonged jaundice in males and the UGT1A1 G71R polymorphism (p=0.03).
  • Genotype frequencies (homozygous, heterozygous, normal) were detailed for both groups.

Conclusions:

  • There is no statistically significant association between prolonged jaundice and the G71R polymorphism in Gilbert's syndrome.
  • A relationship was identified between male gender and the UGT1A1 G71R polymorphism in the context of prolonged jaundice.
Abstract

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
51
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
967
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
85
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.7K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K